North America Transfection Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Published Report
  • Jan 2021
  • North America
  • 350 Pages
  • No of Tables: 149
  • No of Figures: 55

North America Transfection Market, By Type (Transient Transfection, Stable Transfection), Methods (Non-Viral Methods, Viral Methods), CRISPR Transfection Methods (Non-Viral Methods, Viral Methods), Products (Reagent & Kits, Instrument, Software), Organism (Mammalian Cells, Plants, Fungi, Virus, Bacteria), Types of Molecule (Plasmid DNA, Small Interfering RNA (siRNA), Proteins, DNA Oligonucleotides, Ribonucleoprotein Complexes (RNPs), Others), Application (In Vitro Application, In Vivo Application, Bioproduction, Others), Stage (Research, Preclinical, Clinical Phases, Commercial), End User (Biopharma, Contract Research Organizations (CROs), Contract Manufacturing Organization/ Contract Development and Manufacturing Organization (CMOs/CDMOs), Academia, Hospitals, Clinical Labs, Others), Distribution Channel (Direct Tender, Retail Sales, Others), Country (U.S., Canada, Mexico) Industry Trends and Forecast to 2028

North America Transfection MarketMarket Analysis and Insights: North America Transfection Market

The transfection market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 9.4% in the forecast period of 2021 to 2028 and is expected to reach USD 1,112.33 million by 2028. Development of synthetic biology products and large-scale transfections used in clinical research are the major drivers which propelled the demand of the market in the forecast period.

The transfection method is used to introduce RNA, DNA or protein products in cells to alter the phenotype and genotype of the organism. Transfection method involves the new gene transfer or transferring a gene construct such as clustered regularly interspaced short palindromic repeats (CRISPR) for genome editing purposes. Transfection has wide applications in the field of immunotherapy, gene therapy and cell therapy among others. Transfection involves both non-viral and viral mediated transfection. The chemical and physical methods can achieve non – viral transfection.

The rise in the prevalence of chronic disease is acting as a driver for the transfection market growth. The high cost of instruments acts as restraint for the transfection market growth. The exploration of emerging markets is acting as an opportunity for the transfection market growth. The long approval procedure acts as challenge for the transfection market growth.

The transfection market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the transfection market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

North America Transfection MarketNorth America Transfection Market Scope and Market Size

The transfection market is segmented on the basis of the type, methods, CRISPR transfection methods, products, organism, types of molecule, application, stage, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of type, the transfection market is segmented into transient transfection and stable transfection. In 2021, transient transfection segment is dominating as it obtains transfection result in less span of time, this is the reason this method is widely employed for large scale protein production.
  • On the basis of methods, the transfection market is segmented into non-viral methods and viral methods. In 2021, non-viral methods segment is dominating as these methods provides with the high transfection efficiency and less chances of infection to cultured cells.
  • On the basis of CRISPR transfection methods, the transfection market is segmented into non-viral methods and viral methods. In 2021, non-viral methods segment is dominating for CRISPR (clustered regularly interspaced short palindromic repeats) transfection as it offers allows efficient delivery of CRISPR sequences to targeted cell lines.
  • On the basis of products, the transfection market is segmented into reagents & kits, instrument and software. In 2021, reagent & kits segment is dominating as these are used for enhancing the efficacy of transfection process in various genetic experiments, as well as other biological experiments and industrial applications.
  • On the basis of organism, the transfection market is segmented into mammalian cells, plants, fungi, virus and bacteria. In 2021, mammalian cells segment is dominating as mammalian cell transfection is commonly used to express exogenous nucleic acid molecules in a host cell line using many different ways for production of monoclonal antibodies, follicle stimulating hormone, and other products as compared to other types of cells.
  • On the basis of types of molecule, the transfection market is segmented into plasmid DNA, small interfering RNA (siRNA), proteins, DNA oligonucleotides, ribonucleoprotein complexes (RNPs) and others. In 2021, plasmid DNA segment is dominating in the transfection market as plasmid DNA can be transferred by most of the transfection products discovered.
  • On the basis of application, the transfection market is segmented into in vitro application, in vivo application, bioproduction and others. In 2021, in vitro application segment is dominating as it provides with the delivery of cargo nucleic acid molecules into cultured cells which has a crucial role in research as well as for commercial production of molecules.
  • On the basis of stage, the transfection market is segmented into research, preclinical, clinical phases and commercial. In 2021, research segment is dominating in the market due to increasing demand for gene expression for production of novel molecules in different biological fields.
  • On the basis of end user, the transfection market is segmented into biopharma, contract research organizations (CROs), contract manufacturing organization/contract development and manufacturing organization (CMOs/CDMOs), academia, hospitals, clinical labs and others. In 2021, biopharma segment hold the largest market share because of the increasing demand to improve efficiency & speed of transfection so as to produce desired cell lines.
  • On the basis of distribution channel, the transfection market is segmented into direct tender, retail sales and others. In 2021, direct tender segment is dominating in the market these are the primary source of procurement for transfection instruments, reagents and kits, moreover biopharma industries are largely dependent on direct tenders.

Transfection Market Country Level Analysis

The transfection market is analyzed and market size information is provided on the basis of country, type, methods, CRISPR transfection methods, products, organism, types of molecule, application, stage, end user and distribution channel as referenced above.

The countries covered in North America transfection market report are the U.S., Canada, and Mexico.

Transient transfection segment in North America region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because of ongoing development of synthetic biology products. The U.S. is leading the growth due to increasing government support and growing need of chimeric genes for several therapeutic purposes.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Growing Demand of Chimeric Genes and Increasing Government Support are Boosting the Market Growth of Transfection

The transfection market also provides you with detailed market analysis for every country growth in transfection industry with transfection drugs sales, impact of advancement in the transfection technology and changes in regulatory scenarios with their support for the transfection market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Transfection Market Share Analysis

The transfection market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to transfection market.

The major companies which are dealing in the transfection market are Mirus Bio LLC., Promega Corporation, Bio-Rad Laboratories, Inc., Merck KGaA, Lonza, MaxCyte, Inc., Altogen Biosystems, SBS Genetech, FUJIFILM Irvine Scientific (A Subsidiary of FUJIFILM Holdings Corporation), Avanti Polar Lipids (A Subsidiary of Croda International Plc), Cytiva, Geno Technology Inc., USA, R&D Systems, Inc., Takara Bio Inc., Thermofisher Scientific Inc., QIAGEN, OriGene Technologies, Inc., Applied Biological Materials Inc. (abm), Beckman Coulter, Inc. (A Subsidiary of Danaher), Amyris, Codexis, SignaGen Laboratories, Impossible Foods Inc., Genlantis Inc., Zymergen Inc., Ginkgo Bioworks, Verve Therapeutics, Inc., Conagen, Inc., Poseida Therapeutics, Inc. and Twist Bioscience among other domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launches and agreements are also initiated by the companies’ worldwide which are also accelerating the transfection market.

For instance,

  • In November 2017, Mirus Bio LLC. launched TransIT-VirusGEN Transfection Reagent, for large scale production of adeno- associated virus and lentivirus in suspension cell culture. This product launch boosted the company’s product portfolio and allowed it to attain a lucrative growth.

Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market players is enhancing the company market in the transfection market which also provides the benefit for organization to improve their offering for transfection.

Customization Available: North America Transfection Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES

TABLE 1 LIST OF APPROVED ANTIBODIES PRODUCED IN CHO CELLS

TABLE 2 EU DIRECTIVES AND REGULATIONS RELATED TO CLINICAL TRIALS INVOLVING GTMPS

TABLE 3 GOVERNMENT ENTITIES THAT ARE IN CHARGE OF TYPE 2 USES

TABLE 4 NORTH AMERICA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)

TABLE 5 NORTH AMERICA TRANSIENT TRANSFECTION IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 6 NORTH AMERICA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 7 NORTH AMERICA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 8 NORTH AMERICA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 9 NORTH AMERICA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 10 NORTH AMERICA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 11 NORTH AMERICA NON- VIRAL METHODS IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 12 NORTH AMERICA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 13 NORTH AMERICA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 14 NORTH AMERICA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 15 NORTH AMERICA VIRAL METHODS IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 16 NORTH AMERICA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 17 NORTH AMERICA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 18 NORTH AMERICA NON- VIRAL METHODS IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 19 NORTH AMERICA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 20 NORTH AMERICA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 21 NORTH AMERICA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 22 NORTH AMERICA VIRAL METHODS IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 23 NORTH AMERICA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 24 NORTH AMERICA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 25 NORTH AMERICA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 26 NORTH AMERICA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 27 NORTH AMERICA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 28 NORTH AMERICA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 29 NORTH AMERICA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 30 NORTH AMERICA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 31 NORTH AMERICA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 32 NORTH AMERICA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 33 NORTH AMERICA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 34 NORTH AMERICA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 35 NORTH AMERICA SOFTWARE BY INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 36 NORTH AMERICA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)

TABLE 37 NORTH AMERICA MAMMALIAN CELLS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 38 NORTH AMERICA PLANTS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 39 NORTH AMERICA FUNGI IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 40 NORTH AMERICA VIRUS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 41 NORTH AMERICA BACTERIA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 42 NORTH AMERICA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)

TABLE 43 NORTH AMERICA PLASMID DNA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 44 NORTH AMERICA BACTERIA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 45 NORTH AMERICA PROTEINS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 46 NORTH AMERICA DNA OLIGONUCLEOTIDES IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 47 NORTH AMERICA RIBONUCLEOPROTEIN COMPLEXES (RNPS) IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 48 NORTH AMERICA BACTERIA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 49 NORTH AMERICATRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 50 NORTH AMERICA IN VITRO APPLICATION IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 51 NORTH AMERICA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 52 NORTH AMERICA IN VIVO APPLICATION IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 53 NORTH AMERICA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 54 NORTH AMERICA BIOPRODUCTION IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 55 NORTH AMERICA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 56 NORTH AMERICA OTHERS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 57 NORTH AMERICA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 58 NORTH AMERICA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 59 NORTH AMERICA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 60 NORTH AMERICA AGRICULTURE IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 61 NORTH AMERICA OTHERS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 62 NORTH AMERICA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 63 NORTH AMERICA RESEARCH IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 64 NORTH AMERICA PRE-CLINICAL IN TRANSFECTION MARKET, BY REGION, 2017-2027 (USD MILLION)

TABLE 65 NORTH AMERICA CLINICAL PHASES IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 66 NORTH AMERICA COMMERCIAL IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 67 NORTH AMERICA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 68 NORTH AMERICA BIOPHARMA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 69 NORTH AMERICA CONTRACT RESEARCH ORGANIZATIONS (CROS) IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 70 NORTH AMERICA CONTRACT MANUFACTURING ORGANIZATION/ CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION (CMOS/CDMOS) IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 71 NORTH AMERICA ACADEMIA IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 72 NORTH AMERICA HOSPITALS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 73 NORTH AMERICA CLINICAL LABS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 74 NORTH AMERICA OTHERS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 75 NORTH AMERICA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 76 NORTH AMERICA DIRECT TENDER IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 77 NORTH AMERICA RETAIL SALES IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 78 NORTH AMERICA OTHERS IN TRANSFECTION MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 1 NORTH AMERICA TRANSFECTION MARKET, BY COUNTRY, 2018-2028 (USD MILLION)

TABLE 2 NORTH AMERICA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)

TABLE 3 NORTH AMERICA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 4 NORTH AMERICA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 5 NORTH AMERICA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 6 NORTH AMERICA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 7 NORTH AMERICA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 8 NORTH AMERICA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 9 NORTH AMERICA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 10 NORTH AMERICA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 11 NORTH AMERICA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 12 NORTH AMERICA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 13 NORTH AMERICA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 14 NORTH AMERICA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 15 NORTH AMERICA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 16 NORTH AMERICA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 17 NORTH AMERICA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 18 NORTH AMERICA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 19 NORTH AMERICA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 20 NORTH AMERICA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 21 NORTH AMERICA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 22 NORTH AMERICA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 23 NORTH AMERICA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 24 NORTH AMERICA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 25 NORTH AMERICA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 26 NORTH AMERICA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)

TABLE 27 NORTH AMERICA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 28 NORTH AMERICA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)

TABLE 29 NORTH AMERICA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)

TABLE 30 NORTH AMERICATRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 31 NORTH AMERICA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 32 NORTH AMERICA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 33 NORTH AMERICA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 34 NORTH AMERICA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 35 NORTH AMERICA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 36 NORTH AMERICA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 37 NORTH AMERICA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 38 NORTH AMERICA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 39 U.S. TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)

TABLE 40 U.S. TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 41 U.S. TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 42 U.S. STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 43 U.S. STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 44 U.S. TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 45 U.S. NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 46 U.S. CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 47 U.S. PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 48 U.S. VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 49 U.S. CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 50 U.S. NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 51 U.S. CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 52 U.S. PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 53 U.S. VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 54 U.S. TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 55 U.S. REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 56 U.S. CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 57 U.S. LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 58 U.S. NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 59 U.S. CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 60 U.S. KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 61 U.S. NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 62 U.S. INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 63 U.S. INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)

TABLE 64 U.S. ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 65 U.S. TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)

TABLE 66 U.S. TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)

TABLE 67 U.S. TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 68 U.S. IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 69 U.S. IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 70 U.S. BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 71 U.S. TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 72 U.S. SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 73 U.S. TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 74 U.S. TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 75 U.S. TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 76 CANADA TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)

TABLE 77 CANADA TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 78 CANADA TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 79 CANADA STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 80 CANADA STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 81 CANADA TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 82 CANADA NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 83 CANADA CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 84 CANADA PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 85 CANADA VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 86 CANADA CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 87 CANADA NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 88 CANADA CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 89 CANADA PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 90 CANADA VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 91 CANADA TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 92 CANADA REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 93 CANADA CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 94 CANADA LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 95 CANADA NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 96 CANADA CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 97 CANADA KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 98 CANADA NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 99 CANADA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 100 CANADA INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)

TABLE 101 CANADA ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 102 CANADA TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)

TABLE 103 CANADA TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)

TABLE 104 CANADA TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 105 CANADA IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 106 CANADA IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 107 CANADA BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 108 CANADA TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 109 CANADA SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 110 CANADA TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 111 CANADA TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 112 CANADA TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 113 MEXICO TRANSFECTION MARKET, BY TYPE, 2018-2028 (USD MILLION)

TABLE 114 MEXICO TRANSIENT TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 115 MEXICO TRANSIENT TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 116 MEXICO STABLE TRANSFECTION (BY STAGE) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 117 MEXICO STABLE TRANSFECTION (BY PRODUCT) IN TRANSFECTION MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 118 MEXICO TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 119 MEXICO NON-VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 120 MEXICO CHEMICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 121 MEXICO PHYSICAL IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 122 MEXICO VIRAL METHODS IN TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 123 MEXICO CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 124 MEXICO NON-VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 125 MEXICO CHEMICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 126 MEXICO PHYSICAL IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 127 MEXICO VIRAL METHODS IN CRISPR TRANSFECTION MARKET, BY METHODS, 2019-2028 (USD MILLION)

TABLE 128 MEXICO TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 129 MEXICO REAGENTS & KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 130 MEXICO CATIONIC LIPIDS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 131 MEXICO LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 132 MEXICO NON-LIPOSOMAL REAGENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 133 MEXICO CATIONIC POLYMER IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 134 MEXICO KITS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 135 MEXICO NANOPARTICLES IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 136 MEXICO INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 137 MEXICO INSTRUMENTS IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (UNITS)

TABLE 138 MEXICO ELECTROPORATION SYSTEM IN TRANSFECTION MARKET, BY PRODUCTS, 2019-2028 (USD MILLION)

TABLE 139 MEXICO TRANSFECTION MARKET, BY ORGANISM, 2019-2028 (USD MILLION)

TABLE 140 MEXICO TRANSFECTION MARKET, BY TYPES OF MOLECULE, 2019-2028 (USD MILLION)

TABLE 141 MEXICO TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 142 MEXICO IN VITRO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 143 MEXICO IN VIVO APPLICATION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 144 MEXICO BIOPRODUCTION IN TRANSFECTION MARKET (BY TYPE), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 145 MEXICO TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 146 MEXICO SYNTHETIC BIOLOGY IN TRANSFECTION MARKET (BY INDUSTRY), BY APPLICATION, 2019-2028 (USD MILLION)

TABLE 147 MEXICO TRANSFECTION MARKET, BY STAGE, 2019-2028 (USD MILLION)

TABLE 148 MEXICO TRANSFECTION MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 149 MEXICO TRANSFECTION MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

 

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions